Low Hepatic Toxicity in Primary and Metastatic Liver Cancers after Stereotactic Ablative Radiotherapy Using 3 Fractions.

In conclusion, SABR using 3 fractions in primary and metastatic liver cancers produces low hepatic toxicity, especially in patients with a baseline CP score of 5. However, further studies are needed to minimize hepatic toxicity in patients with baseline CP scores≥6. PMID: 26240482 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/26240482?dopt=Abstract

Source: J Korean Med Sci - August 1, 2015 Category: Journals (General) Authors: Bae SH, Kim MS, Jang WI, Cho CK, Yoo HJ, Kim KB, Han CJ, Park SC, Lee DH Tags: J Korean Med Sci Source Type: research